Trump picks former congressman and vaccine injury advocate to lead CDCnews2024-11-23T03:08:59+00:00November 23rd, 2024|Endpoints News|
Trump picks Johns Hopkins researcher Marty Makary to lead the FDAnews2024-11-23T01:11:39+00:00November 23rd, 2024|Endpoints News|
FDA approves BridgeBio’s heart disease drug, setting up competition with Pfizer, Alnylamnews2024-11-23T00:15:53+00:00November 23rd, 2024|Endpoints News|
FDA adcomm raises risk questions on AstraZeneca’s Andexxanews2024-11-21T21:14:50+00:00November 21st, 2024|Endpoints News|
Jazz wins approval for bispecific in biliary tract cancernews2024-11-21T19:17:39+00:00November 21st, 2024|Endpoints News|
FDA updates label of 33-year-old cancer drug with new dose and warningnews2024-11-20T20:54:38+00:00November 20th, 2024|Endpoints News|
When generative AI meets the FDA: First digital health adcomm kicks off discussionnews2024-11-20T18:52:15+00:00November 20th, 2024|Endpoints News|
GSK plots regulatory filings for PBC itch after positive Phase 3 readoutnews2024-11-19T20:53:31+00:00November 19th, 2024|Endpoints News|
FDA rejects Astellas’ effort to support longer use of Izervay news2024-11-19T19:50:39+00:00November 19th, 2024|Endpoints News|
FDA raises safety questions on AstraZeneca’s bleeding reversal agentnews2024-11-19T19:37:40+00:00November 19th, 2024|Endpoints News|
